{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0006955",
      "entity_text" : "immune response",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ08175",
      "entity_text" : "AAV",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Although adeno associated virus (AAV) vector systems have been developed to deliver full-length or nano sized dysferlin genes into dysferlin deficient mice and non human primates with encouraging results XREF_BIBR, XREF_BIBR, AAV can trigger immune response that limits its therapeutic efficacy upon repeat treatment.",
  "reading_complete" : "2020-08-02T18:00:35Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T17:59:33Z",
  "trigger" : "trigger",
  "evidence" : [ "AAV can trigger immune response" ],
  "pmc_id" : "5835933",
  "score" : 0
}